Weight loss medications, including GLP-1 receptor agonists like tirzepatide, exert their effects primarily through appetite suppression, delayed gastric emptying, and improved insulin sensitivity
Carrying extra weight places additional stress on weight-bearing joints like knees and hips, and body fat produces inflammatory proteins that can damage cartilage over time
The tolerability comparison therefore involves comparing an approved, monitored compound against one still generating Phase 3 safety data
Randomized trials in non-GLP-1 populations show that reducing carbohydrate fermentation lowers breath hydrogen and gas-related symptoms, supporting this mechanism., Plain-English explanation why carbs sit longer and make more gas In simple terms, slower digestion gives gut bacteria more time to work on carbohydrates
Unlike classical medications, tirzepatide operates as a dual agonist, simultaneously activating GLP-1 and GIP receptors
The first few weeks are the ones in which the medication has the greatest effect